Fatty pancreas prevalence 30.5% and linked to higher pancreatitis, cancer risk
Fatty pancreas is linked to higher risk of pancreatic cancer
This meta-analysis of 124 studies including 141,416 healthy or routine-examination participants found a fatty pancreas prevalence of 30.5%, …
A fatty pancreas is common and linked to a higher risk of serious conditions like pancreatic cancer and diabetes.
Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM
Pharmacist-led care improves blood sugar for woman with long-term diabetes
This case report describes a single patient with type 2 diabetes who received pharmacist-led medication therapy management. The intervention…
A pharmacist-led review helped a woman with a 30-year history of Type 2 Diabetes significantly improve her medication adherence and blood su…
Citrus grandis Tomentosa flavonoids ameliorate hepatic steatosis and inflammatory responses in experimental MASLD models
Citrus flavonoids show potential in treating fatty liver disease
This scoping review synthesizes preclinical data on the efficacy of Citrus grandis Tomentosa (CGT) flavonoids in metabolic dysfunction-assoc…
New research suggests specific citrus compounds may reduce inflammation and fat buildup in the liver, offering a possible path for future tr…
Epigallocatechin-3-gallate shows positive therapeutic effects on various digestive system diseases in animal models
Green tea compound shows potential for several digestive diseases
This meta-analysis of 63 preclinical studies involving 738 animals indicates that Epigallocatechin-3-gallate (EGCG) has a positive therapeut…
A review of animal studies suggests a green tea compound could help treat various cancers and digestive conditions.
Systematic Review: Flavonoids from Traditional Chinese Medicine Show Promise for NAFLD
Flavonoids from Chinese medicine show promise for fatty liver disease
This systematic review examines flavonoids from traditional Chinese medicine for non-alcoholic fatty liver disease. The authors report that …
A systematic review suggests flavonoids from traditional Chinese medicine may improve liver health in humans and animals by reducing fat and…
Narrative review of palmitoleic acid links to metabolic health and fatty liver outcomes
Palmitoleic Acid Shows Mixed Links to Metabolic Health
This narrative review examines palmitoleic acid (POA) supplementation and food matrices regarding insulin resistance, fatty liver, and hyper…
Higher palmitoleic acid levels are tied to fatty liver and insulin resistance, but supplements show neutral effects.
Hepatic steatosis prevalence and impact in autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis
Fatty liver makes autoimmune hepatitis and PBC worse, but not PSC
This systematic review and meta-analysis of 19,898 patients with autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing c…
A large review found fatty liver is common in autoimmune liver diseases and makes outcomes worse for some patients, but not others.
Narrative review explores gut metabolites postbiotics obesity fatty liver and bone loss associations
Your Gut Microbes May Be Secretly Stealing Your Bone Strength
This narrative review examines the relationship between gut metabolites, postbiotics, and conditions including obesity, fatty liver, and bon…
A leaky gut can block calcium and vitamin D from reaching your bones, raising fracture risk.
Hepatic steatosis compromises APRI and FIB-4 accuracy for staging fibrosis in chronic hepatitis B patients
Does fatty liver ruin the accuracy of common blood tests for scarring in hepatitis B?
This retrospective cohort study evaluated treatment-naïve Han Chinese patients with chronic hepatitis B to assess how concurrent hepatic ste…
Fatty liver makes common blood tests for hepatitis B scarring nearly useless, dropping accuracy from 90% to under 50% and causing dangerous …
Research across Metabolic Dysfunction-Associated Steatotic Liver Disease
Related studies from across the Metabolic Dysfunction-Associated Steatotic Liver Disease family.
Dioscin shows therapeutic potential for various liver disorders including MASLD and hepatocellular carcinoma
Plant Compound Dioscin Shows Promise For Liver Disease
This systematic review evaluates the hepatoprotective effects and pharmacokinetics of Dioscin in various liver diseases. The review conclude…
A plant compound called Dioscin may help protect the liver, but human evidence is still missing and high doses carry risks.
MASLD linked to 35% higher odds of HFpEF in pooled analysis of 899,629 patients
Liver Disease Linked to Higher Risk of Heart Failure
This meta-analysis of 3 studies (899,629 patients, 47,610 with MASLD) found that MASLD was associated with higher odds of clinically diagnos…
People with metabolic dysfunction-associated steatotic liver disease (MASLD) show a higher risk of developing heart failure with preserved e…
Ketogenic diets and intermittent fasting may improve weight, insulin sensitivity, and hepatic steatosis in MASLD
Ketogenic diets and fasting may improve liver health in patients
This narrative review examines the impact of ketogenic dietary interventions and intermittent fasting on patients with metabolic dysfunction…
New research suggests that ketogenic diets and intermittent fasting can help manage weight and liver fat in people with metabolic liver dise…
Viral hepatitis infections pose significantly higher risk for liver cancer than smoking-related lung cancer
Comparing the risks of liver cancer from hepatitis versus lung cancer from smoking
This meta-analysis of 86,097,714 participants analyzed the relative risks of liver cancer from various exposures compared to lung cancer fro…
New data shows that certain hepatitis viruses pose a much higher risk for liver cancer than smoking does for lung cancer.
Efficacy of High-Intensity Interval Training and Moderate-Intensity Continuous Training in MASLD
Exercise Types Improve Liver Health in MASLD Patients
Meta-analysis confirms that both HIIT and MICT significantly improve body composition, cardiometabolic markers, and liver function in MASLD …
High-intensity interval training and moderate continuous exercise both help MASLD patients. They improve body composition, metabolism, and l…
rs2896019 G allele associated with 51% increased risk of MASLD susceptibility
Genetic variant linked to increased risk of fatty liver disease
This meta-analysis of 15028 adults identified the rs2896019 polymorphism (G allele) as a significant risk factor for MASLD. The study found …
A specific genetic marker may significantly increase the risk of developing and progressing to severe fatty liver disease.
Low fat-free mass metrics are associated with increased risk of weight-related metabolic complications
Low muscle mass increases risk of diabetes and heart disease
This meta-analysis of observational studies involving 138,935 adults with overweight or obesity found that low fat-free mass (FFM) metrics a…
New data shows that having less fat-free mass is linked to a higher risk of developing type 2 diabetes and heart disease in adults.
Telmisartan leads to modest fasting blood sugar reduction in patients with MASLD
Telmisartan Shows Modest Effects on Blood Sugar in Liver Disease
This meta-analysis of 258 adults with MASLD found that telmisartan resulted in a modest reduction in fasting blood sugar of -2.78 mg/dL. Oth…
A review of clinical data suggests that the medication telmisartan may lower fasting blood sugar in adults with certain types of liver disea…
Clinical trials for MASLD show limited racial and ethnic diversity despite increasing Hispanic enrollment
Clinical trials for fatty liver disease lack diversity
This meta-analysis of 91 randomized controlled trials evaluates racial and ethnic diversity in MASLD clinical trials. While Hispanic enrollm…
Most fatty liver disease trials underreport ethnicity, and Black patients are only 2.5% of participants, despite the disease's impact.
Fibrosis-informed markers provide a decision architecture for statin allocation in intermediate-risk MASLD patients
New guidelines help doctors choose statins for liver disease patients
This guideline proposes a decision-making framework for statin therapy in the intermediate-risk stratum for patients with MASLD. It utilizes…
Doctors now have a clearer way to decide who needs statin treatment when liver health and heart risk overlap.
AI, machine learning, and deep learning models facilitate multimodal diagnosis and prognosis in MASLD
Artificial intelligence helps identify and predict fatty liver disease
This scoping review synthesizes 73 studies regarding the role of AI, machine learning, and deep learning in diagnosing and predicting outcom…
New technology is helping doctors identify fatty liver disease and predict its progress by analyzing complex data and medical images.
Phytochemicals modulate miRNA-mediated regulatory networks to influence metabolic reprogramming and cancer-associated signaling
Phytochemicals May Influence RNA Networks Linked to Chronic Diseases
This narrative review explores how phytochemicals interact with miRNA-mediated regulatory networks through transcriptional, epigenetic, and …
New research explores how plant-based compounds might influence genetic switches that play a role in cancer and metabolic disorders.
Questions about fatty liver
Are gut metabolites linked to obesity and conditions like fatty liver?
Yes, gut metabolites like short-chain fatty acids and bile acids are linked to obesity and fatty liver, with dysbiosis driving inflammation and metabolic dysfunction.
Full answer →Do quercetin and apigenin show promise for treating non-alcoholic fatty liver disease?
Yes, quercetin and apigenin show promise for NAFLD by reducing liver fat and inflammation, but most evidence comes from lab and animal studies; human trials are limited.
Full answer →Can the compound EGCG help treat digestive system diseases and fatty liver?
EGCG shows promise for treating fatty liver and other digestive diseases in animal and lab studies, but human trials are still needed to confirm its effectiveness.
Full answer →